ATE389636T1 - Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung - Google Patents

Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung

Info

Publication number: ATE389636T1
Authority: AT; Austria
Prior art keywords: substituted pyridine; diseases; compounds; pharmaceutical use; maladies
Prior art date: 1997-12-19

Application number

AT98965447T

Other languages

English (en)

Inventor

Nathan Mantlo

Chan Hwang

Ulrike Spohr

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-19

Filing date

1998-12-21

Publication date

2008-04-15

1998-12-18 Priority claimed from US09/215,426 external-priority patent/US6174901B1/en

1998-12-21 Application filed by Amgen Inc filed Critical Amgen Inc

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE389636T1 publication Critical patent/ATE389636T1/de

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title abstract 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title abstract 2
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical class C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 title 1
201000010099 disease Diseases 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
238000000034 method Methods 0.000 abstract 3
206010028980 Neoplasm Diseases 0.000 abstract 2
208000002193 Pain Diseases 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
206010012601 diabetes mellitus Diseases 0.000 abstract 2
238000011321 prophylaxis Methods 0.000 abstract 2
238000011282 treatment Methods 0.000 abstract 2
GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
102000003777 Interleukin-1 beta Human genes 0.000 abstract 1
108090000193 Interleukin-1 beta Proteins 0.000 abstract 1
108090001005 Interleukin-6 Proteins 0.000 abstract 1
102000004890 Interleukin-8 Human genes 0.000 abstract 1
108090001007 Interleukin-8 Proteins 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
150000004892 pyridazines Chemical class 0.000 abstract 1
150000003222 pyridines Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Obesity (AREA)
Virology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

AT98965447T 1997-12-19 1998-12-21 Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung ATE389636T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6819997P	1997-12-19	1997-12-19
US09/215,426 US6174901B1 (en)	1998-12-18	1998-12-18	Substituted pyridine and pyridazine compounds and methods of use

Publications (1)

Publication Number	Publication Date
ATE389636T1 true ATE389636T1 (de)	2008-04-15

Family

ID=26748691

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98965447T ATE389636T1 (de)	1997-12-19	1998-12-21	Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung

Country Status (15)

Country	Link
EP (1)	EP1042293B9 (de)
JP (1)	JP2001526263A (de)
KR (1)	KR20010033241A (de)
CN (1)	CN1284945A (de)
AT (1)	ATE389636T1 (de)
AU (1)	AU755421B2 (de)
CA (1)	CA2315827C (de)
DE (1)	DE69839278T2 (de)
DK (1)	DK1042293T3 (de)
ES (1)	ES2304797T3 (de)
HU (1)	HUP0101099A3 (de)
IL (1)	IL136711A0 (de)
PT (1)	PT1042293E (de)
SI (1)	SI1042293T1 (de)
WO (1)	WO1999032448A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6350744B1 (en) *	1998-11-20	2002-02-26	Merck & Co., Inc.	Compounds having cytokine inhibitory activity
WO2000040243A1 (en)	1999-01-08	2000-07-13	Smithkline Beecham Corporation	Novel compounds
US6602872B1 (en) *	1999-12-13	2003-08-05	Merck & Co., Inc.	Substituted pyridazines having cytokine inhibitory activity
AU1898700A (en) *	1999-12-20	2001-07-03	Gho'st Holding B.V.	Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and NA+/H+ exchange inhibitor
PL207853B1 (pl) *	2000-04-04	2011-02-28	Fundacja Rozwoju Diagnostyki I Terapii	Nowe (1-adamantyloamino)pirydyny, sposób ich wytwarzania i zastosowanie medyczne
US6562807B2 (en)	2000-06-23	2003-05-13	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
US6664256B1 (en) *	2000-07-10	2003-12-16	Kowa Co., Ltd.	Phenylpyridazine compounds and medicines containing the same
WO2002040445A1 (en)	2000-11-17	2002-05-23	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
US6821960B2 (en)	2000-11-17	2004-11-23	Noyo Nordisk Pharmaceuticals, Inc.	Glucagon antagonists/inverse agonists
US6706744B2 (en)	2000-11-17	2004-03-16	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
EP1343763A1 (de)	2000-11-20	2003-09-17	Bristol-Myers Squibb Company	Pyrodon-derivate als ap2 inhibitoren
WO2003006023A1 (en)	2001-07-13	2003-01-23	Bristol-Myers Squibb Company	Pyrazinone inhibitors of fatty acid binding protein and method
US6762318B2 (en)	2001-12-03	2004-07-13	Novo Nordisk A/S	Glucagon antagonists
US6881746B2 (en)	2001-12-03	2005-04-19	Novo Nordick A/S	Glucagon antagonists/inverse agonists
US7196106B2 (en)	2002-11-05	2007-03-27	Merck & Co., Inc	Cyanothiophene derivatives, compositions containing such compounds and methods of use
SE0203654D0 (sv) *	2002-12-09	2002-12-09	Astrazeneca Ab	New compounds
AU2004210127B2 (en)	2003-01-27	2009-10-01	Merck Sharp & Dohme Corp.	Substituted pyrazoles, compositions containing such compounds and methods of use
EP1650195A4 (de) *	2003-07-30	2008-09-17	Kowa Co	Verfahren zur inhibierung der produktion von osteopontin
CA2547785A1 (en)	2003-12-19	2005-07-21	Merck & Co., Inc.	Cyclic guanidines, compositions containing such compounds and methods of use
ES2241496B1 (es) *	2004-04-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridina.
NZ551405A (en)	2004-06-04	2009-06-26	Merck & Co Inc	Pyrazole derivatives, compositions containing such compounds and methods of use
US8318760B2 (en)	2005-03-21	2012-11-27	Merck Sharp & Dohme Corp.	Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use
JP2008534593A (ja)	2005-03-30	2008-08-28	メルクエンドカムパニーインコーポレーテッド	グルカゴン受容体アンタゴニスト化合物、そのような化合物を含む組成物、及びその使用方法
ES2600460T3 (es)	2005-05-10	2017-02-09	Intermune, Inc.	Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
CN101300232A (zh)	2005-07-26	2008-11-05	默克公司	合成取代的吡唑的方法
ES2270715B1 (es)	2005-07-29	2008-04-01	Laboratorios Almirall S.A.	Nuevos derivados de pirazina.
ES2274712B1 (es)	2005-10-06	2008-03-01	Laboratorios Almirall S.A.	Nuevos derivados imidazopiridina.
TW200745031A (en)	2005-10-13	2007-12-16	Merck & Co Inc	Acyl indoles, compositions containing such compounds and methods of use
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
US7989472B2 (en)	2006-03-23	2011-08-02	Merck Sharp & Dohme Corp.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
US7935713B2 (en)	2006-05-16	2011-05-03	Merck Sharp & Dohme Corp.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TW200821284A (en)	2006-10-03	2008-05-16	Merck & Co Inc	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
SI2203439T1 (sl)	2007-09-14	2011-05-31	Ortho Mcneil Janssen Pharm	1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
CN102099036B (zh)	2008-06-03	2015-05-27	英特芒尼公司	用于治疗炎性疾患和纤维化疾患的化合物和方法
EP2344470B1 (de)	2008-09-02	2013-11-06	Janssen Pharmaceuticals, Inc.	3-azabicyclo[3.1.0]hexylderivate als modulatoren von metabotropen glutamatrezeptoren
JP5690277B2 (ja)	2008-11-28	2015-03-25	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
BRPI1010831A2 (pt)	2009-05-12	2016-04-05	Addex Pharmaceuticals Sa	derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439008B (zh)	2009-05-12	2015-04-29	杨森制药有限公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
AU2011328203B2 (en)	2010-11-08	2015-03-19	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
ES2536433T3 (es)	2010-11-08	2015-05-25	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US9271967B2 (en)	2010-11-08	2016-03-01	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
NZ611529A (en)	2010-12-23	2015-06-26	Pfizer	Glucagon receptor modulators
WO2012107850A1 (en)	2011-02-08	2012-08-16	Pfizer Inc.	Glucagon receptor modulator
US8927577B2 (en)	2011-07-22	2015-01-06	Pfizer Inc.	Quinolinyl glucagon receptor modulators
AR092742A1 (es)	2012-10-02	2015-04-29	Intermune Inc	Piridinonas antifibroticas
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
EP3065736B1 (de)	2013-11-04	2018-11-14	Merck Sharp & Dohme Corp.	Glucagon-rezeptor-antagonist-verbindungen, zusammensetzungen daraus und verfahren zur verwendung
MX386697B (es)	2014-01-21	2025-03-19	Janssen Pharmaceutica Nv	Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
ME03518B (de)	2014-01-21	2020-04-20	Janssen Pharmaceutica Nv	Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
MX382781B (es)	2014-04-02	2025-03-13	Intermune Inc	Piridinonas anti-fibroticas.
RU2738844C2 (ru) *	2016-04-14	2020-12-17	Гуанчжоу Джойо Фарматек Ко., Лтд	Содержащее заместитель, представляющий собой бутан, в гетероциклическом кольце производное пиридона для лечения фиброза и воспалительных заболеваний
EP3684364A4 (de)	2017-09-18	2021-06-02	Goldfinch Bio, Inc.	Pyridazinone und verfahren zur verwendung davon
WO2021122645A1 (en)	2019-12-20	2021-06-24	Syngenta Crop Protection Ag	Pesticidally active azole-amide compounds
IL305573A (en)	2021-03-15	2023-10-01	Saul Yedgar	HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL6816241A (de) *	1967-12-01	1969-06-03
JPH01258671A (ja) *	1987-12-01	1989-10-16	Morishita Pharmaceut Co Ltd	５−（１ｈ−イミダゾール−１−イル）−３（２ｈ）−ピリダジノン誘導体
US5461053A (en) *	1989-02-07	1995-10-24	Sanofi	Pyridazine derivatives
FR2663326B2 (fr) *	1989-11-17	1992-10-16	Sanofi Sa	Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
WO1992002513A1 (en) *	1990-08-06	1992-02-20	Fujisawa Pharmaceutical Co., Ltd.	Heterocyclic compounds
US5686470A (en) *	1995-02-10	1997-11-11	Weier; Richard M.	2, 3-substituted pyridines for the treatment of inflammation
JP3294616B2 (ja) *	1995-08-10	2002-06-24	メルクエンドカンパニーインコーポレーテッド	２−置換アリールピロール、このような化合物を含む組成物及び使用方法
WO1997005878A1 (en) *	1995-08-10	1997-02-20	Merck & Co., Inc.	2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
KR20000067910A (ko) *	1996-07-18	2000-11-25	에프. 아. 프라저, 에른스트 알테르 (에. 알테르), 한스 페터 비틀린 (하. 페. 비틀린), 피. 랍 보프, 브이. 스펜글러, 페. 아에글러	자외선 흡수제로서의 폴리옥시알킬렌으로 치환 및 가교된 트리아
IL127441A (en) *	1996-07-18	2003-02-12	Merck Frosst Canada Inc	Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
JP3335132B2 (ja) *	1997-11-19	2002-10-15	興和株式会社	新規ピリダジン誘導体及びこれを有効成分とする医薬

1998
- 1998-12-21 IL IL13671198A patent/IL136711A0/xx unknown
- 1998-12-21 JP JP2000525385A patent/JP2001526263A/ja active Pending
- 1998-12-21 WO PCT/US1998/027298 patent/WO1999032448A1/en not_active Ceased
- 1998-12-21 CA CA002315827A patent/CA2315827C/en not_active Expired - Fee Related
- 1998-12-21 DK DK98965447T patent/DK1042293T3/da active
- 1998-12-21 PT PT98965447T patent/PT1042293E/pt unknown
- 1998-12-21 AU AU20911/99A patent/AU755421B2/en not_active Ceased
- 1998-12-21 AT AT98965447T patent/ATE389636T1/de not_active IP Right Cessation
- 1998-12-21 KR KR1020007006660A patent/KR20010033241A/ko not_active Ceased
- 1998-12-21 ES ES98965447T patent/ES2304797T3/es not_active Expired - Lifetime
- 1998-12-21 SI SI9830907T patent/SI1042293T1/sl unknown
- 1998-12-21 EP EP98965447A patent/EP1042293B9/de not_active Expired - Lifetime
- 1998-12-21 CN CN98813653A patent/CN1284945A/zh active Pending
- 1998-12-21 DE DE69839278T patent/DE69839278T2/de not_active Expired - Fee Related
- 1998-12-21 HU HU0101099A patent/HUP0101099A3/hu unknown

Also Published As

Publication number	Publication date
WO1999032448A8 (en)	2001-04-19
DK1042293T3 (da)	2008-07-14
ES2304797T3 (es)	2008-10-16
AU755421B2 (en)	2002-12-12
DE69839278T2 (de)	2008-09-11
AU2091199A (en)	1999-07-12
EP1042293B9 (de)	2008-09-03
SI1042293T1 (sl)	2008-08-31
HUP0101099A2 (hu)	2001-10-28
JP2001526263A (ja)	2001-12-18
CN1284945A (zh)	2001-02-21
IL136711A0 (en)	2001-06-14
KR20010033241A (ko)	2001-04-25
EP1042293A1 (de)	2000-10-11
WO1999032448A1 (en)	1999-07-01
HUP0101099A3 (en)	2002-09-30
CA2315827A1 (en)	1999-07-01
EP1042293B1 (de)	2008-03-19
PT1042293E (pt)	2008-04-18
CA2315827C (en)	2007-08-21
DE69839278D1 (de)	2008-04-30

Legal Events

Date

Code

Title

Description

2008-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1042293

Country of ref document: EP

2010-09-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE389636T1 (de)	2008-04-15	Substituierte pyridin- und pyridazinderivate und ihre pharmazeutische verwendung
DE69838070D1 (de)	2007-08-23	Substituierte pyridin-derivate als entzündungshemmende mittel
ATE323705T1 (de)	2006-05-15	Substituierte indolizinähnliche verbindungen und ihre verwendung
WO1998024782A3 (en)	1998-08-27	Substituted pyrimidine compounds and their use
ATE320426T1 (de)	2006-04-15	Harnstoffderivate und ihre verwendung
PT948495E (pt)	2004-08-31	Agentes anti-inflamatorios de pirrolo fundido substituidos em arilo e heteroarilo
WO1998024780A3 (en)	1998-07-30	Substituted pyrimidinone and pyridinone compounds and their use
NO971816L (no)	1997-06-18	Farmasöytisk blanding for behandling av sykdommer forårsaket av IL-6 produksjon
EE200300324A (et)	2003-12-15	Asendatud alküülamiini derivaadid ja nende kasutamismeetodid
IS8175A (is)	2005-12-12	Píperasín afleiður og aðferðir við notkun þeirra
EA200401319A1 (ru)	2005-04-28	Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
ATE271861T1 (de)	2004-08-15	Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ES2189165T3 (es)	2003-07-01	Nuevos compuestos macrociclicos como inhibidores de metaloproteasa.
CA2274063A1 (en)	1998-06-11	Substituted pyrimidine compounds and their use
WO2006041888A3 (en)	2007-09-07	Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
EP1314732A3 (de)	2004-01-02	Substituierte Pyrimidinverbindungen und ihre Verwendung
ATE355287T1 (de)	2006-03-15	2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten